Milgamma

Benfotiamine, the active ingredient in Milgamma, is a vitamin supplement presented as an oral formulation for supporting peripheral nerve health and managing symptoms of diabetic neuropathy. It works together with pyridoxine hydrochloride (vitamin B6) to address deficiencies of vitamins B1 and B6.

GNH USA supplies Milgamma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring consistent quality, regulatory compliance, and reliable supply chain management for healthcare providers.

Milgamma, a combined benfotiamine and pyridoxine supplement, is used to support nerve function and address vitamin B1/B6 deficiencies. - Peripheral nerve health: helps maintain nerve function and reduce discomfort in conditions affecting peripheral nerves. - Diabetic neuropathy: may alleviate symptoms such as tingling, burning, or pain associated with diabetic nerve damage. - Vitamin B1 and B6 deficiency: provides essential thiamine and pyridoxine to prevent or correct deficiencies.

Milgamma may be associated with the following adverse reactions, which are generally mild and reversible.

Common Side Effects: - Gastrointestinal discomfort: mild nausea, abdominal cramps, or dyspepsia. - Skin reactions: rash or pruritus at the site of exposure. - Headache: transient mild headache.

Serious or Rare Side Effects: - Hypersensitivity: anaphylactic reaction, swelling of face or throat. - Hematologic changes: rare cases of leukopenia or thrombocytopenia. - Severe liver injury: extremely uncommon reports of hepatitis.

When using Milgamma, consider the following precautions. - Pregnancy: safety not established; use only if clearly needed. - Breastfeeding: insufficient data; evaluate risk versus benefit. - Renal impairment: monitor as vitamin B6 accumulation may occur. - Drug interactions: review concomitant medications that affect vitamin metabolism. - Underlying conditions: assess for existing neuropathy causes before use. - Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture and light.

Milgamma can interact with other medicines; monitor accordingly.

Major Interactions (Avoid): - Anticonvulsants (e.g., phenobarbital): may increase vitamin B6 metabolism, reducing efficacy. - High‑dose pyridoxine: can cause sensory neuropathy; avoid concurrent high supplemental doses.

Moderate Interactions (Monitor Closely): - Chemotherapy agents (e.g., cisplatin): may potentiate neurotoxicity; monitor nerve function. - Oral contraceptives: possible alteration in vitamin metabolism; observe for side effects. - Alcohol: excessive intake can impair thiamine utilization; advise moderation.